What’s Next for Craneware?
Despite walking away from what could’ve been a transformative acquisition, Craneware appears unshaken. The company is doubling down on its internal roadmap, confident that its trajectory in the healthcare software sector—where it provides revenue cycle and cost management tools to hospitals and health systems—remains strong and upward-bound.
As the dust settles, one thing is clear: in a market driven by bold takeovers and billion-dollar buyouts, Craneware chose independence over undervaluation, and Bain Capital—at least for now—missed its shot.
